Recommended Citation
Michael Jon Andersen,
Bound Guidance: FDA Rulemaking for Off-Label Pharmaceutical Drug Marketing, 60 Case W. Rsrv. L. Rev. 531 (2010)
Available at:
https://scholarlycommons.law.case.edu/caselrev/vol60/iss2/9
Skip to main content
COinS
ISSN: 0008-7262
Contact the Law Review
11075 East Blvd.
Cleveland, Ohio 44106
Email:
Phone: 216.368.3312
Follow Case Western Law Review
on X: 
Case Western Reserve Law Review
on LinkedIn: 
Follow @cwrulawreview on Instagram: 